CYC 2.10% $1.40 cyclopharm limited

Ann: SNMMI Announcement Regarding USFDA Approval of Technegas, page-10

  1. 43 Posts.
    lightbulb Created with Sketch. 1
    It’s totally perplexing to me. The previous highs in 2022 exceeded the post-approval high. The approval itself has been presented with more promise than I was hoping for. I had prepared myself for an FDA rejection and a walloping but this outcome has really caught me off guard. Topping up because I really believe this is a bargain at this price but it will only make sense if the market wakes up to it… here’s hoping!
 
watchlist Created with Sketch. Add CYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.